PRZ-SPIRONOLACTONE DIN 02567229
Health Canada record
| Active ingredient(s) | SPIRONOLACTONE 100 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | C03DA01 SPIRONOLACTONE |
| Original market date | |
| Current status date | 01-Apr-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Pharmaris Canada Inc. — licence 3-002451, currently licensed, last inspection rating C (2023-01-19).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing SPIRONOLACTONE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02518848 | JAMP SPIRONOLACTONE | JAMP PHARMA CORPORATION | Tablet | SPIRONOLACTONE 100 MG | Marketed |
| 02518821 | JAMP SPIRONOLACTONE | JAMP PHARMA CORPORATION | Tablet | SPIRONOLACTONE 25 MG | Marketed |
| 02488159 | MINT-SPIRONOLACTONE | MINT PHARMACEUTICALS INC | Tablet | SPIRONOLACTONE 100 MG | Marketed |
| 02488140 | MINT-SPIRONOLACTONE | MINT PHARMACEUTICALS INC | Tablet | SPIRONOLACTONE 25 MG | Marketed |
| 00613223 | TEVA-SPIRONOLACTONE | TEVA CANADA LIMITED | Tablet | SPIRONOLACTONE 100 MG | Marketed |
| 00613215 | TEVA-SPIRONOLACTONE | TEVA CANADA LIMITED | Tablet | SPIRONOLACTONE 25 MG | Marketed |
| 00613231 | TEVA-SPIRONOLACTONE/HCTZ | TEVA CANADA LIMITED | Tablet | SPIRONOLACTONE 25 MG; HYDROCHLOROTHIAZIDE 25 MG | Marketed |
| 00657182 | TEVA-SPIRONOLACTONE/HCTZ | TEVA CANADA LIMITED | Tablet | SPIRONOLACTONE 50 MG; HYDROCHLOROTHIAZIDE 50 MG | Marketed |
| 00180408 | ALDACTAZIDE 25 | PFIZER CANADA ULC | Tablet | SPIRONOLACTONE 25 MG; HYDROCHLOROTHIAZIDE 25 MG | Cancelled Post Market |
| 00594377 | ALDACTAZIDE 50 | PFIZER CANADA ULC | Tablet | SPIRONOLACTONE 50 MG; HYDROCHLOROTHIAZIDE 50 MG | Cancelled Post Market |
| 00285455 | ALDACTONE 100 MG | PFIZER CANADA ULC | Tablet | SPIRONOLACTONE 100 MG | Cancelled Post Market |
| 00028606 | ALDACTONE 25 MG | PFIZER CANADA ULC | Tablet | SPIRONOLACTONE 25 MG | Cancelled Post Market |
| 00520802 | APO-SPIROZIDE TAB | APOTEX INC | Tablet | SPIRONOLACTONE 25 MG; HYDROCHLOROTHIAZIDE 25 MG | Cancelled Post Market |
| 02347628 | NTP-SPIRONOLACTONE | NT PHARMA CANADA LTD | Tablet | SPIRONOLACTONE 100 MG | Cancelled Pre Market |
| 02347601 | NTP-SPIRONOLACTONE | NT PHARMA CANADA LTD | Tablet | SPIRONOLACTONE 25 MG | Cancelled Pre Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 37256 | 2026-04-01 | Abbreviated New Drug Submission (ANDS) |
International API supply for SPIRONOLACTONE
2 valid EDQM Certificates of Suitability from 2 holders. 9 active FDA Drug Master Files.
Request a quote for PRZ-SPIRONOLACTONE